Skip to content Synspira
Synspira Mobile Menu Toggle navigation
  • About
    • Who We Are
    • Our Focus
    • Leadership
    • Board
      of Directors
  • Therapeutic Areas
    • Pulmonary
      Disease
  • Product Development
  • News & Publications
    • Press Releases
    • Publications
      & Abstracts
  • Contact
  • About
    • Who We Are
    • Our Focus
    • Leadership
    • Board
      of Directors
  • Therapeutic Areas
    • Pulmonary
      Disease
  • Product Development
  • News & Publications
    • Press Releases
    • Publications
      & Abstracts
  • Contact

Author: Kathryn Kilroy

Synspire Pharmaceuticals Novel Glycopolymer Improves Effectiveness of Antibiotics Against Drug-resistant Bacteria Associated with Cystic Fibrosis

Posted on July 12, 2017May 10, 2023 by Kathryn Kilroy

Continue reading “Synspire Pharmaceuticals Novel Glycopolymer Improves Effectiveness of Antibiotics Against Drug-resistant Bacteria Associated with Cystic Fibrosis”

Posted in Press Releases

Novel glycopolymer sensitizes Burkholderia cepacia complex isolates from cystic fibrosis patients to tobramycin and meropenem

Posted on June 29, 2017May 11, 2023 by Kathryn Kilroy
Posted in Presentations

Posts navigation

Newer posts
  • Privacy Policy
  • Terms & Conditions
  • FCOI Policy

©2025 Synspire Pharmaceuticals, Inc.

All Rights Reserved.